Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosomal miRNAs in autoimmune skin diseases. | Front Immunol | 2023 | 38106405 | PubTator, text mining | PubMed |
| Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma. | Elife | 2023 | 38099574 | PubTator, text mining | PubMed |
| DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies. | Front Immunol | 2023 | 38090585 | PubTator, text mining | PubMed |
| Alteration in Melanin Content in Retinal Pigment Epithelial Cells upon Hydroquinone Exposure. | Int J Mol Sci | 2023 | 38069124 | PubTator, text mining | PubMed |
| Comprehensive identification of onco-exaptation events in bladder cancer cell lines revealed L1PA2-SYT1 as a prognosis-relevant event. | iScience | 2023 | 38058305 | PubTator, text mining | PubMed |
| Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study. | Front Genet | 2023 | 38028607 | PubTator, text mining | PubMed |
| Antibiotic resistance genes prevalence prediction and interpretation in beaches affected by urban wastewater discharge. | One Health | 2023 | 38024281 | PubTator, text mining | PubMed |
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. | Front Immunol | 2023 | 38022659 | PubTator, text mining | PubMed |
| Canonical Wnt and TGF-β/BMP signaling enhance melanocyte regeneration but suppress invasiveness, migration, and proliferation of melanoma cells. | Front Cell Dev Biol | 2023 | 38020918 | PubTator, text mining | PubMed |
| TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale. | Cells | 2023 | 37998358 | PubTator, text mining | PubMed |
| Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression. | BMC Chem | 2023 | 37993971 | PubTator, text mining | PubMed |
| Domain-adaptive neural networks improve supervised machine learning based on simulated population genetic data. | PLoS Genet | 2023 | 37934781 | PubTator, text mining | PubMed |
| Editorial: Exploiting genetics and genomics to improve the understanding of eye diseases. | Front Genet | 2023 | 37920854 | PubTator, text mining | PubMed |
| Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers. | Infect Agent Cancer | 2023 | 37915098 | PubTator, text mining | PubMed |
| Acral melanoma: new insights into the immune and genomic landscape. | Neoplasia | 2023 | 37913653 | PubTator, text mining | PubMed |
| Assessment of in vitro anti-skin aging activities of Phyllanthus indofischeri Bennet extracts for dermatological and aesthetic applications. | Sci Rep | 2023 | 37907639 | PubTator, text mining | PubMed |
| Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models. | J Immunother Cancer | 2023 | 37899133 | PubTator, text mining | PubMed |
| Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma. | Cell Death Dis | 2023 | 37898636 | PubTator, text mining | PubMed |
| Plant Extracts as Skin Care and Therapeutic Agents. | Int J Mol Sci | 2023 | 37895122 | PubTator, text mining | PubMed |
| A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options. | Sci Adv | 2023 | 37889972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=10